St. Lucia, Australia

Rink-Jan Lohman

This inventor holds 1 USPTO granted patent. Top assignee: The University of Queensland. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rink-Jan Lohman. Retrieved from https://idiyas.com/inventor/rink-jan-lohman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rink-Jan Lohman: Innovator in Pharmaceutical Research

Introduction

Rink-Jan Lohman is a notable inventor based in St. Lucia, Australia. He has made significant contributions to the field of pharmaceutical research, particularly in the development of novel compounds for therapeutic applications.

Latest Patents

Lohman holds a patent for "Modulators of protease activated receptors." This invention provides novel compounds of the Formula (I), pharmaceutical compositions comprising such compounds, and methods for using these compounds as tools for biological studies or as agents for therapies. These therapies target conditions such as metabolic syndrome, obesity, type II diabetes, fibrosis, and cardiovascular diseases, whether used alone or in combination with other treatment modalities.

Career Highlights

Lohman is affiliated with The University of Queensland, where he engages in cutting-edge research. His work focuses on the intersection of pharmacology and therapeutic development, contributing to advancements in medical science.

Collaborations

Lohman collaborates with esteemed colleagues, including David P. Fairlie and Ligong Liu, who contribute to his research endeavors and enhance the impact of his work.

Conclusion

Rink-Jan Lohman's innovative research and patent contributions are paving the way for new therapeutic options in the medical field. His work exemplifies the importance of collaboration and innovation in addressing complex health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…